So Mi Jemma Cho
@somijemmacho
CV Epidemiologist @MassGeneralNews|@BroadInstitute; alum: @UCBerkeley|@BerkeleyLab|@iSEVERANCE
ID:1426345592247263234
14-08-2021 00:51:20
509 Tweets
364 Followers
282 Following
Global study in The Lancet Public Health reveals stark differences in major causes of disease burden between females and males, underscoring the need for gender-responsive approaches to health. hubs.li/Q02vFZ2m0
Great to see this paper out led by
Kathryn Foti John William McEvoy.
Modeling the Impact of Biomarker-Guided Versus ASCVD Risk–Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004 ahajournals.org/doi/abs/10.116…
There is a ceiling effect of BP lowering treatment benefits (nadir 125/75mmHg) with a higher residual risk in secondary prevention. 'The earlier, the better' prevails over 'the lower, the better' Dimitrios Farmakis
ahajrnls.org/4aYGgoT
happy to see our review on SGLT2i - from bench to bedside now online, highlighted as editor's choice CVR Tomasz Guzik
grateful to co-lead this article with a great scientist & friend Luca Liberale
👉 doi.org/10.1093/cvr/cv…
Federico Carbone CardioTomLuscher European Society of Cardiology Journals European Society of Cardiology
Recently I have done more #HTN work, but I also do behavioral cardiology work. Here are the primary results of my @NHLBI funded work. Translational Research of the Acute Effects of Negative Emotions on Vascular Health: pubmed.ncbi.nlm.nih.gov/38690710/ AHA Science JAHA Columbia Medicine
Higher income variability, income declines and sustained low income associated with increased cardiovascular risk! Read it on #EHJ !
academic.oup.com/eurheartj/adva…
#EHJ #cardiotwitter #diabetes #income #variability European Society of Cardiology Journals European Society of Cardiology
#PRECISION Trial
In patients with resistant #HTN , #aprocitentan was well tolerated and superior to placebo in lowering BP at week 4 with a sustained effect at week 40
thelancet.com/journals/lance… The Lancet #NephTwitter #CardioTwitter Dr Anastasia Mihailidou FAHA FCSANZ FESC Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Joel M. Topf, MD FACP
Now in #EJPC European Society of Cardiology Journals, Christian Faaborg Andersen MD MGH IM Residents 🔎s Lp(a) testing 🧪 across Mass General Brigham 2000-2023
66,937 Lp(a) assays
5.8% w/ coronary 🫀 dz had testing
⬇️ testing in women (OR 0.73), Black pts (0.58)
Testing more common *after* CHD dx
👇
academic.oup.com/eurjpc/advance…
Effects of Reduced Dietary Sodium and the DASH Diet on GFR:
Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS et al
ASN Kidney360
journals.lww.com/kidney360/full…
Was invited to participate in upcoming AHA meeting in November. So glad to see that #Hypertension is now list as specialty to declare 👍. It did not exist as a choice and I always complain about it. way to go Amit Khera
Happy to share our review on single pill combination therapy for treatment of hypertension #antoniococa #miguelcamafort Jose Patricio Lopez Lopez Seamus Whelton UW Cardiology Johns Hopkins Ciccarone Center Daichi Shimbo MD Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS European Journal of Internal Medicine
sciencedirect.com/science/articl…
📣 PROMPT LIPID trial is out!
✅ EHR-based decision support tools promote guideline-concordant, high-value, quality care for patients with very high risk ASCVD
Check out our editorial 🔥 Johns Hopkins Ciccarone Center Johns Hopkins Cardiology Jelani K. Grant Seth Martin
ahajournals.org/doi/10.1161/CI…
#Metabolic health and #cardiometabolic risk #clusters : implications for prediction, prevention, and treatment thelancet.com/journals/landi…
#subphenotypes #diabetes #obesity #CVD